New MMR vaccine tested in african children to match established protection
NCT ID NCT06399003
Summary
This study tested a new MMR vaccine made by Shanghai Institute of Biological Products to see if it works as well as an already approved vaccine from GSK. It involved 1,200 healthy African children aged 9-11 months. Researchers compared the children's immune responses and monitored for any side effects after vaccination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEASLES-MUMPS-RUBELLA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Victoria Biomedical Research Institute(VIBRI)
Kisumu, Kenya
Conditions
Explore the condition pages connected to this study.